Directory
>
Catherine Burgess
Catherine Burgess
Group Leader - Genomics | Dynavax Technologies
Massachusetts, Boston, United States
Catherine Burgess
Summary
Catherine Burgess is a seasoned executive in the field of regulatory affairs with extensive experience in oncology and emerging markets. With a PhD from Eastern Virginia Medical School and a strong background in project management, she has successfully led cross-functional teams across multiple countries. Catherine's career includes significant leadership roles at renowned pharmaceutical companies such as Bristol Myers Squibb and Takeda, where she has been instrumental in developing regulatory strategies for biologics and small molecules. Currently, she serves as Vice President and Head of Regulatory Affairs at Dynavax Technologies. Catherine's unique blend of scientific expertise and strategic insight enables her to navigate complex regulatory landscapes effectively. Fluent in Swedish, she brings a global perspective to her work, enhancing her ability to lead diverse teams and projects. Her commitment to advancing therapeutic innovations is evident in her extensive work with clinical trials and strategy development.
Catherine Burgess
Work Experience
Vice President, Head of Regulatory Affairs at
Dynavax Technologies
October 2022 - Present
Catherine Burgess
Education
Karolinska Institute, Postdoc
January 1995 - January 1998
Eastern Virginia Medical School, PhD
January 1989 - January 1994
Old Dominion University, B.S.
January 1982 - January 1987
Frequently Asked Questions about Catherine Burgess
What is Catherine Burgess email address?
Catherine Burgess's primary email address is *****************@takeda.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Catherine Burgess work for?
Catherine Burgess is a Group Leader - Genomics at Dynavax Technologies.
Where Catherine Burgess graduated from?
Catherine Burgess holds a degree in null from Karolinska Institute.
How can I directly contact Catherine Burgess?
To contact Catherine Burgess directly, you can use the email address *****************@takeda.com. Complete contact information is available upon registration with Muraena.
Who is Catherine Burgess?
Catherine Burgess is a seasoned executive in the field of regulatory affairs with extensive experience in oncology and emerging markets. With a PhD from Eastern Virginia Medical School and a strong background in project management, she has successfully led cross-functional teams across multiple countries. Catherine's career includes significant leadership roles at renowned pharmaceutical companies such as Bristol Myers Squibb and Takeda, where she has been instrumental in developing regulatory strategies for biologics and small molecules. Currently, she serves as Vice President and Head of Regulatory Affairs at Dynavax Technologies. Catherine's unique blend of scientific expertise and strategic insight enables her to navigate complex regulatory landscapes effectively. Fluent in Swedish, she brings a global perspective to her work, enhancing her ability to lead diverse teams and projects. Her commitment to advancing therapeutic innovations is evident in her extensive work with clinical trials and strategy development.
Catherine`s contact details
*****************@takeda.com
*********@takedajobs.com
********@dynavax.com
Colleagues
Student Technology Assistant, Training & Communications, Information Technology Services
Medical Information Specialist, Medical Information
Process Operator
Design Engineer - Senior Design Engineer - Research Engineer
EMBO Fellowship (Post-Doc)
Associate Director
Process Engineer
Merck Manufacturing Development Program
EA to President; EA to VP Market Data; EA to VP Sales
Chief Executive Officer